๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Paclitaxel and Cisplatin Combination Chemotherapy in Recurrent Epithelial Ovarian Cancer

โœ Scribed by Jeffrey M. Goldberg; M.Steven Piver; Ronald E. Hempling; Fernando O. Recio

Book ID
115617012
Publisher
Elsevier Science
Year
1996
Tongue
English
Weight
83 KB
Volume
63
Category
Article
ISSN
0090-8258

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Ifosfamide, paclitaxel and cisplatin fir
Ifosfamide, paclitaxel and cisplatin first-line chemotherapy in advanced, suboptimally debulked epithelial ovarian cancer
โœ Christos A. Papadimitriou; Charalambos Kouroussis; Lia A. Moulopoulos; Georgios ๐Ÿ“‚ Article ๐Ÿ“… 2001 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 97 KB ๐Ÿ‘ 1 views

## BACKGROUND. The combination of paclitaxel with a platinum analogue is the preferred chemotherapy regimen in the treatment of advanced epithelial ovarian carcinoma. The alkylating agent ifosfamide has shown activity in refractory or recurrent ovarian cancer. We conducted a Phase II study with th

Cisplatin- based chemotherapy of epithel
Cisplatin- based chemotherapy of epithelial ovarian cancer
โœ Howard D. Homesley ๐Ÿ“‚ Article ๐Ÿ“… 1989 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 500 KB

The current International Federation of Gynecology and Obstetrics (FIGO) staging system, independent prognostic factors, and review of the Gynecologic Oncology Group (GOG) studies in epithelial ovarian carcinoma are presented. With this background, approaches using cisplatinbased regimens in ovarian